运动皮层神经元过度兴奋与α-Synuclein聚合相关
Liqiang Chen1,2,3, Hiba Douja Chehade1,2,3, Hong-Yuan Chu1,2,3
1Aligning Science Across Parkinson's (ASAP) Collaborative Research Network, Chevy Chase, MD, 20852, United States.
bioRxiv : the preprint server for biology
|August 2, 2024
概括
帕金森病 (PD) 涉及大脑中的Lewy病理. 这项研究表明,运动皮层神经元中的α-synuclein聚合会导致过度兴奋,从而导致PD.
科学领域:
- 神经科学是一个神经科学.
- 神经病理学神经病理学
- 运动障碍 运动障碍
背景情况:
- 大脑皮层功能障碍导致帕金森病 (PD) 的运动和认知缺陷.
- 勒维病理破坏皮质电路并与PD中的多巴胺类变性相互作用的确切机制尚不清楚.
- 调查皮层Lewy病理对于理解PD病变的产生至关重要.
研究的目的:
- 在帕金森病 (PD) 的小鼠模型中调查α-synuclein (αSyn) 聚合如何影响皮质电路完整性和功能.
- 确定αSyn病理对运动皮层内不同神经元亚型的特定影响.
- 探索皮层αSyn沉积和中脑多巴胺基神经元退化在PD中的关系.
主要方法:
- 将α-synuclein (αSyn) 预制纤维素 (PFFs) 注入小鼠的背侧条纹体,以诱导病理.
- 在特定的皮层层和神经元亚型 (脑内神经元 (ITN) 和皮层神经元 (CSN)) 中分析αSyn总量分布.
- 电生理学记录以评估神经元的内在兴奋性,输入抵抗和形态变化 (体质大小,树突棘).
主要成果:
- 与CSN相比,αSyn聚合物在运动皮层内优先积累在ITN中.
- αSyn负载的ITN表现出增加的内在刺激性和输入阻力,以及体质收缩和树突性脊柱损失.
- 中脑多巴胺能神经元退化和相关的条状多巴胺枯竭并没有改变CSN内在刺激能力或thalamocortical输入.
结论:
- 运动皮质神经元中的αSyn聚合导致神经元过激,为帕金森病 (PD) 中皮质功能障碍提供了一个新的机制.
- 这些发现突出了皮层神经元对αSyn病理学的细胞类型特异性脆弱性.
- 这项研究提供了Lewy病理和皮质电路中断在PD之间的机制联系.
更多相关视频
10:03Studying Pre-formed Fibril Induced α-Synuclein Accumulation in Primary Embryonic Mouse Midbrain Dopamine Neurons
Published on: August 16, 2020
10.6K
09:16Exogenous Administration of Microsomes-associated Alpha-synuclein Aggregates to Primary Neurons As a Powerful Cell Model of Fibrils Formation
Published on: June 26, 2018
7.5K
相关概念视频
01:37Neural Regulation
39.2K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.2K
01:15Parkinson's Disease: Overview
510
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
510
03:03Amyloid Fibrils
9.5K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.5K